These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36844484)

  • 21. The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release.
    Nawarawong W; Wyshock E; Meloni FJ; Weitz J; Schmaier AH
    Br J Haematol; 1991 Oct; 79(2):296-301. PubMed ID: 1958489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of fibrinopeptide A in survivors of cerebral infarction.
    Landi G; Barbarotto R; Morabito A; D'Angelo A; Mannuccio Mannucci P
    Stroke; 1990 Mar; 21(3):424-7. PubMed ID: 2137945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool.
    Southan C; Lane DA; Knight I; Ireland H; Bottomley J
    Biochem J; 1985 Aug; 229(3):723-30. PubMed ID: 4052020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased fibrinopeptide A during anginal attacks in patients with variant angina.
    Irie T; Imaizumi T; Matuguchi T; Koyanagi S; Kanaide H; Takeshita A; Nakamura M
    J Am Coll Cardiol; 1989 Sep; 14(3):589-94; discussion 595-6. PubMed ID: 2768708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasma fibrinopeptide A, fibrinopeptide B beta 15-42 and 4 other coagulation factors levels in patients with diabetic retinopathy].
    Yamamoto M; Denno S; Sunakawa M
    Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1443-8. PubMed ID: 1476075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry.
    Ebert MP; Niemeyer D; Deininger SO; Wex T; Knippig C; Hoffmann J; Sauer J; Albrecht W; Malfertheiner P; Röcken C
    J Proteome Res; 2006 Sep; 5(9):2152-8. PubMed ID: 16944926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acid sequences of lamprey fibrinopeptides A and B and characterizations of the junctions split by lamprey and mammalian thrombins.
    Cottrell BA; Doolittle RF
    Biochim Biophys Acta; 1976 Dec; 453(2):426-38. PubMed ID: 999898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
    Mullin JL; Gorkun OV; Binnie CG; Lord ST
    J Biol Chem; 2000 Aug; 275(33):25239-46. PubMed ID: 10837485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM; Mullin JL; Lord ST
    Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A.
    Koppert PW; Huijsmans CM; Nieuwenhuizen W
    Blood; 1985 Sep; 66(3):503-7. PubMed ID: 4040783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):967-76. PubMed ID: 3365373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated fibrinopeptide A levels in patients with clinically localised breast carcinoma.
    Auger MJ; Galloway MJ; Leinster SJ; McVerry BA; Mackie MJ
    Haemostasis; 1987; 17(6):336-9. PubMed ID: 3428719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the location in the thrombin B chain of substrate recognition sites for fibrinopeptide release and factor XIII activation.
    Pirkle H; Theodor I; Christofferson M; Vukasin P; Miyada D
    Thromb Res; 1989 Sep; 55(6):737-46. PubMed ID: 2781534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
    Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The action of thrombin on modified fibrinogen.
    Osbahr AJ
    Thromb Haemost; 1983 Jun; 49(3):208-13. PubMed ID: 6410533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibody to plasma fibrinopeptide A in a patient with a severe acquired haemorrhagic syndrome.
    Gris JC; Schved JF; Branger B; Aguilar-Martinez P; Vécina F; Oulès R; Sarlat C; Fourcade J
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):519-29. PubMed ID: 1450318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro.
    Moore PK; Hussaini I; Bhardwaj R
    Eur J Pharmacol; 1988 Aug; 153(2-3):231-8. PubMed ID: 3053211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen Zurich I: impaired release of fibrinopeptide A.
    Hofmann V; Gati WP; Straub PW
    Thromb Haemost; 1979 Jun; 41(4):709-13. PubMed ID: 483244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.